Table 2.

Laboratory investigations at presentation

		Reference range
Serum luteinizing hormone, mIU/mL	<0.30	FP: 1.76-10.24, OP: 2.19-88.33, LP: 1.13-14.22
Serum follicle-stimulating hormone, mIU/mL	4.86	FP: 3.01-14.72, OP: 3.21-16.60, LP: 1.47-8.49
Serum estradiol, pg/mL	1564.0	FP: 28.8-196.8, OP: 36.4-525.9, LP: 44.1-491.9
Serum progesterone, ng/mL	39.9	FP: ≤0.28, OP: ≤5.69, LP: 2.05-24.2
Serum prolactin, ng/mL	65.60	4.91-29.32
Serum growth hormone, ng/mL	1.78	0.13-9.88
Serum insulin-like growth factor-1, ng/mL	121	137-320
Serum testosterone, ng/mL	<0.03	0.11-0.47
Plasma adrenocorticotropin, pg/mL	24.70	7.2–63.3
Serum cortisol, μg/mL	10.1	7.07-19.6
Serum thyrotropin, μIU/mL	1.652	0.61-4.23
Serum free thyroxine, ng/dL	0.83	0.75-1.45
Urine human chorionic gonadotropin	Negative	Negative
Serum carbohydrate antigen 125, U/mL	208	≤35.0
Serum carcinoembryonic antigen, ng/mL	1.6	≤5.0
Serum carbohydrate antigen 19-9, U/mL	<2.0	≤37.0
Serum squamous cell carcinoma antigen, ng/mL	0.6	≤2.5
Serum α-fetoprotein, ng/mL	<2.0	≤10.0

Abbreviations: FP, follicular phase; LP, luteal phase; OP, ovulatory phase.